Yale Psychiatry Grand Rounds: May 7, 2021
.
Yale Psychiatry Grand Rounds: May 7, 2021
May 07, 2021"Augmenting, Dismantling, Disseminating: Clinical Discoveries in Pediatric Anxiety Experimental Psychotherapeutics"
Wendy K. Silverman, PhD, Alfred A. Messer Professor of Child Psychiatry, Yale Child Study Center
Information
- ID
- 6574
- To Cite
- DCA Citation Guide
Transcript
- 00:00Just want to say how pleased
- 00:02we are to have you here today.
- 00:05And it's my honor to introduce Doctor
- 00:07Wendy Silverman who is a who is the Alfred,
- 00:11a MSR professor of child psychiatry and
- 00:13director of the Anxiety and Mood Disorders
- 00:16Program at the Yale Child Study Center.
- 00:20Doctor Silverman received her
- 00:21PhD in clinical psychology from
- 00:24Case Western Reserve University,
- 00:25and she's been at the Yale University for
- 00:29quite some time now following her training.
- 00:33Over the course of her career, she is really.
- 00:37She's published numerous scientific
- 00:38papers and chapters in the area of
- 00:41child and adolescent anxiety disorders,
- 00:42including five books of note.
- 00:44She developed the Anxiety Disorders
- 00:46interview scheduled for Children,
- 00:48which is widely used in
- 00:50research and practice.
- 00:52In addition to her scholarly papers,
- 00:54she's been the principal investigator or Co.
- 00:57Investigator on National Institute
- 00:58of Mental Health Research Grants
- 01:00to develop and evaluate treatments
- 01:02for anxiety disorders in children,
- 01:04adolescents.
- 01:04She served as the chairperson of the
- 01:07NIH Intervention Grant Review Panel and
- 01:10as an associate editor and editor of
- 01:12many of the major preeminent journals
- 01:15in clinical psychology and as a
- 01:17reflection of her stature in the field.
- 01:20She is a past president.
- 01:22The Society of Clinical Child
- 01:24and Adolescent Psychology of the
- 01:27American Psychological Association. And
- 01:29perhaps most importantly,
- 01:30in some respects she's been
- 01:32working with anxious youth and
- 01:35their families and supervising
- 01:36trainees for over three decades.
- 01:38So you know she's provided both clinical
- 01:41service but also has seated the next
- 01:44generation of researchers in this area.
- 01:46So today I'm really I want to say
- 01:49how fortunate we are to have the
- 01:52opportunity to learn from you today.
- 01:56From your experience as a clinician,
- 01:58an innovative researcher in the field of
- 02:00child and adolescent anxiety disorders.
- 02:02So thank you very much.
- 02:04OK, well thank you very much Stephanie
- 02:06for that very nice introduction and
- 02:09also thank you for inviting me.
- 02:11It's an honor to be able to present
- 02:14today at Grand rounds in psychiatry.
- 02:17I'm I didn't realize when I was going to
- 02:20begin preparing for this presentation.
- 02:23What actually would have?
- 02:26Wonderful opportunity,
- 02:27it actually provided me to actually
- 02:29stop and sit and reflect on what it is
- 02:33that I've been doing for more than half
- 02:36of my life which is trying to help and
- 02:40understand anxiety disorders in children.
- 02:42And so I think you'll hear throughout
- 02:45my presentation of reflection
- 02:47of some of my reflection.
- 02:49And this also will include a
- 02:52some historical perspective,
- 02:53because I think that historical
- 02:55perspective also helps put the work
- 02:58that will be presenting in some context.
- 03:01So this is the title of my presentation,
- 03:04which I hope will become clearer
- 03:06what it all means.
- 03:08As I get through it the type,
- 03:10the term experimental psychotherapeutics.
- 03:12I actually really love that term.
- 03:14It's not.
- 03:15It's a term from the NIH,
- 03:17and I actually love it because
- 03:19I think it does highlight that
- 03:21we're doing experiment.
- 03:23We're doing extremely well
- 03:24controlled experiments,
- 03:25but it's kind of a handful to be
- 03:27saying this throughout my presentation,
- 03:29so I will be referring to
- 03:32experimental psychotherapeutics.
- 03:33As clinical trials this morning.
- 03:37And this, uh?
- 03:38Stephanie mentioned the interview schedule,
- 03:40which I will be talking about
- 03:43in a few minutes,
- 03:44and I do receive royalties from that,
- 03:47so my objectives for today is to
- 03:50summarize knowledge and identify
- 03:52knowledge gaps in clinical trials
- 03:54of of cognitive behavior therapy,
- 03:56which CBT in my slides of
- 03:59pediatric anxiety disorders.
- 04:00And then this is a journey.
- 04:03So I will be highlighting
- 04:05my journey to enhance CBT.
- 04:07Outcomes and the way I've been
- 04:10trying to do this is by augmenting
- 04:13and dismantling clinical trials
- 04:15and a lot of this work has been
- 04:19with parents and within the past
- 04:22eight to 10 years with attention,
- 04:24retraining methods.
- 04:25And then because I am at heart
- 04:28wanting to really help children and
- 04:31trained clinicians and supervise
- 04:33trainees throughout my presentation,
- 04:35I will be weaving through.
- 04:37The things that we've learned
- 04:39that discoveries clinically,
- 04:40and the implications,
- 04:41and then I'll conclude with the
- 04:43ongoing and future research.
- 04:46Since there is a lot I'm trying
- 04:48to pack in, it's like you know.
- 04:51This is the structure of my presentation.
- 04:54As you'll see some background about the DSM,
- 04:57some background and CBT sampling,
- 04:58then the work with the
- 05:00parents and then and then,
- 05:02which is much of the emphasis
- 05:04and then the attention can be
- 05:06training and some of the takeaways.
- 05:11So I do need to begin with at the beginning,
- 05:15actually, because some people in the
- 05:18audience might not even have been
- 05:21born in when the DSM three came out,
- 05:24which was in 1980 because it was
- 05:26only in 1980 when there was even
- 05:29some things called anxiety disorders
- 05:31in children and adolescents.
- 05:33DSM two just had something
- 05:35called overanxious reaction,
- 05:37so all of a sudden, dear, some.
- 05:39Free in 1980,
- 05:41there was a whole new set of problems
- 05:43that came into existence and I don't,
- 05:46and that's a literal statement.
- 05:48An an I actually began my
- 05:50career in the early 80s,
- 05:52and so this was a ripe opportunity
- 05:54for me to get into something
- 05:56that was brand new and that was
- 05:59exciting and I had done some related
- 06:02fear studies Graduate School,
- 06:04but it was really a brand new opportunity
- 06:07and and we didn't know at the time,
- 06:10but we now know how prevalent
- 06:12these problems are and how the on.
- 06:15Set of these problems begin so early.
- 06:17Median age of onset is 11 and the
- 06:20lifetime prevalence of anxiety
- 06:22disorders is close to 30%.
- 06:24And anybody who knows people with
- 06:26anxiety can know how crippling.
- 06:29And the amount of suffering and
- 06:31burden that they cause on families.
- 06:33An intern on society. This list.
- 06:36There are the slower the anxiety disorders
- 06:38that currently exist in the DSM five.
- 06:41I actually put them in developmental order.
- 06:43So like the ones in the beginning
- 06:46begin more early childhood and then
- 06:48you get more into the middle childhood
- 06:51and then later into adolescence.
- 06:53It's not carved in stone,
- 06:54but there is this general
- 06:56developmental pattern and the in
- 06:58the three disorders with the astrex.
- 07:00Separation,
- 07:01social and geazy.
- 07:02Those are the most common in children
- 07:04and adolescents,
- 07:05and our clinical trials primarily
- 07:07focus on these disorders,
- 07:09and so that's these are the disorders
- 07:12that you'll be hearing most about today
- 07:15that we that we're trying to help.
- 07:18Now when I began my career as I said,
- 07:21there was not much out there and I
- 07:23knew I wanted to help children and
- 07:25I began my career career actually
- 07:27at Suni Albany State University
- 07:29of New York at Albany.
- 07:31David Barlow,
- 07:31who I do view as a mentor and is a,
- 07:34you know,
- 07:35very important person in in
- 07:36the field of adults anxiety.
- 07:38He developed the Adult Anxiety
- 07:40Disorders interview schedule and
- 07:42when I spoke with Dave and I said no,
- 07:44I want to do this for the kids.
- 07:46He says, well, you know.
- 07:48We need an interview for Children,
- 07:50which I did because at that time and
- 07:53still to this day you need to be
- 07:55able to show that you can carefully
- 07:58phenotype the participants and also
- 08:00clinically to know who you're working with.
- 08:03Com ability is rampant and there's
- 08:05a lot of overlapping symptoms an an
- 08:08it is a challenge so I developed
- 08:10the DSM 3 version,
- 08:11the DSM 3R version and then Anne
- 08:14Marie Albano who's sitting there in
- 08:16the corner is my friend and collaborator,
- 08:19Columbia. And she's been a
- 08:20coauthor of the date of the DSM
- 08:22four and season five versions,
- 08:24'cause it's, you know,
- 08:25it's actually quite a bit of work.
- 08:28These anxiety categories are changing
- 08:29with each version of the DSM,
- 08:31and I put the slide up also to let
- 08:34people know for those of you who are
- 08:36doing clinical trials research like and,
- 08:39I thought this was actually kind of cool.
- 08:41Frankly, that since the 80s has become
- 08:43the main measure used in most trials,
- 08:46not just in the United States,
- 08:48but in most in internationally,
- 08:49and it's been translated in many countries.
- 08:52I'm a bunch of us got together and develop
- 08:54this international consensus statement.
- 08:57How do you deal with the different
- 08:59children and different payment reports,
- 09:01the com ability, etc.
- 09:03And then Joan Luby Rd.
- 09:04I thought a nice editorial kind of
- 09:07highlighting that this is a nice
- 09:09template for other clinical trials,
- 09:11so I I think that's one important
- 09:13point about the importance of,
- 09:15especially when doing clinical
- 09:17trials research to make sure that
- 09:19trying to get people, of course.
- 09:22World on the same page on phenotyping.
- 09:26In terms of dimensional measures,
- 09:28which is another important part
- 09:30of our assessment procedure?
- 09:31There's a lot of different measures,
- 09:33and Becca Atkins,
- 09:35a postdoc in our anxiety program and
- 09:37and in the past year we put together
- 09:40this review one there was not too
- 09:43much to put into two separate papers,
- 09:45so we did the child and parent
- 09:47measure separately,
- 09:48and the main takeaway here is,
- 09:51first of all, there are many more studies
- 09:54looking at the use of the Child report.
- 09:57But but still,
- 09:58the pan reportedly in his ID,
- 10:00is also an important indicator,
- 10:01and I mainly just want to put out there
- 10:04that when you look at these measures,
- 10:07the crate they've been looked
- 10:09at pretty much more thoroughly
- 10:10than one might suspect norms,
- 10:12internal consistency,
- 10:13and you can see the list down there
- 10:15and we we came away with the conclusion
- 10:18that these measures actually have
- 10:19good to excellent cycle metrics,
- 10:21and we particularly came away with
- 10:23the idea for the most current for the
- 10:26current measures that the scared.
- 10:28The one that you see the seconds of the
- 10:31end actually has the strongest cycle metrics.
- 10:36So we have phenotyping with interviews Anne
- 10:38with rating scales and another important
- 10:41part of what we do at the anxiety program.
- 10:44Because we do a,
- 10:45you know,
- 10:46we definitely consider all of the
- 10:49units of analysis as per our doc and
- 10:51so we have some novel ways illegally.
- 10:54Poets developed a really cool
- 10:56kinetic motion detecting test task
- 10:58to assess approach and avoidance.
- 11:00And we published some papers on that.
- 11:02You know, we're also doing eye tracking.
- 11:05We do parent child interactions
- 11:07and we measure oxytocin at the
- 11:10same time we do speech tasks.
- 11:12So we do a comprehensive
- 11:14behavioral assessment when the
- 11:15children come through with us.
- 11:17Using these types of methods.
- 11:19We also have been collecting
- 11:21biological and neural targets,
- 11:23and so I mentioned the oxytocin that's
- 11:26the Tiffany necklace at the bottom.
- 11:28That's not a Tiffany necklace that's actually
- 11:31oxytocin and and with Jim Lechman we've,
- 11:33you know, been doing stuff.
- 11:35Really interesting patterns
- 11:37of oxytocin relations with
- 11:39children and their mothers flora.
- 11:41Vaccarino, you know,
- 11:43we've been looking into fibro,
- 11:45glow, fibroblast growth factor,
- 11:48FGF two and looking into bad.
- 11:52Help with Hillary.
- 11:53We've been doing and LNG and psychology.
- 11:56We've been doing brain imaging and
- 11:58collecting data on the children when
- 12:01they're going through our trials.
- 12:03The rainbow figure is genetic work
- 12:05with Tom Fernandez, an Emily Olson,
- 12:07and then we also do collect AEG
- 12:10and this particular paper actually
- 12:12was the data for pilot stuff.
- 12:14The data that served for our current
- 12:17R 01 on attention processing.
- 12:19So we you know, so you know so.
- 12:22The soda is really important to get
- 12:25this type of multimethod assessment,
- 12:27and I'm I'm I'm really pleased,
- 12:29frankly, and I I came in 2013 and
- 12:32I'm actually really pleased with you.
- 12:35Know how well we've been reaching and
- 12:38collaborating with experts in these areas.
- 12:41So that's the measurement part.
- 12:43Now I want to get into the most of what
- 12:45my present my presentation is about,
- 12:48which is about treatment.
- 12:49But you know,
- 12:50assessment.
- 12:50You can have good treatment and
- 12:53evidence based treatments with that
- 12:55that evidence based assessment.
- 12:56So that's why I I emphasize that
- 12:59evidence based based assessment and the.
- 13:02This is.
- 13:02So once we had the anxiety
- 13:05disorders interview schedule,
- 13:06we were able to show that we were
- 13:08able to phenotype the children and
- 13:11Phil Kendall actually was the first
- 13:13person to do the first individual CBT.
- 13:16We did the second group CBT.
- 13:18I'm sorry we did the first we did.
- 13:21First trials showing that you
- 13:23can do CBT in a group format,
- 13:26and this is a data from that trial
- 13:29where we've showed 64% of kids in Group
- 13:32improve 5013 don't the significant
- 13:34time by treatment interactions,
- 13:36but what's interesting is that
- 13:38this this is 1999 in the latest
- 13:41Cochran review where they looked
- 13:43at across the papers of 41 studies.
- 13:46It was remarkable to me how the rates of
- 13:49remission with same basically 59% mission.
- 13:52Versus 15 in the weightless
- 13:53medium to launch effects.
- 13:55Although the durability is an issue
- 13:57and that is varies across the studies,
- 13:59and that's an issue that we're very
- 14:02interested in in trying to work on.
- 14:06And with the cams, is that the largest
- 14:09multi site multi method paper study that
- 14:12came out a while ago and they released
- 14:15their data and so this this is going to?
- 14:18I'm telling you why this is relevant
- 14:21in a moment. So with Michael.
- 14:25Jerome Taylor was a solid fellow and he an
- 14:28myself and Michael Block and Ellie Leibowitz.
- 14:32We Annaly analyze some of the cameras
- 14:34data and we looked at the predictors
- 14:37of poor outcome and what we found in
- 14:41terms of CBT predictors of poor outcome.
- 14:44We found that severe anxiety,
- 14:46especially social anxiety,
- 14:47anxiety and low SES and OC D were main
- 14:51effect predictors of poor outcome.
- 14:54And the cams people looked at their
- 14:57long term naturalistic follow-up
- 14:58and they also found severe anxiety,
- 15:01especially social anxiety worth
- 15:02predictors of poor outcome.
- 15:04I'm going to be coming well.
- 15:06I share this now because this is
- 15:09actually the problem as you see
- 15:11when we do the attention training.
- 15:14This is a large reason why our
- 15:16attention retraining work is
- 15:18focusing on this population.
- 15:20Severe adolescent social anxiety.
- 15:22So that's the reason for
- 15:25bringing this up now.
- 15:27So I will be focusing primarily on efficacy,
- 15:30but I also want to lay for people out there
- 15:34who are interested in effectiveness, work,
- 15:37and the generalizability of this work.
- 15:40I had the honor of being involved
- 15:43in a effectiveness trial.
- 15:45This is Pia Jeppesen,
- 15:47who is a psychiatrist in India in
- 15:50Copenhagen and this she put together
- 15:53a team to see how we can disseminate.
- 15:56CBT the intervention was called
- 15:58mind my mind I was involved in the
- 16:01design and also in developed in
- 16:04consulting on the anxiety modules and
- 16:06you could see here what it's about.
- 16:08The main thing is with anxiety,
- 16:11depression and behavioral disturbances.
- 16:12But using a module eyes approach
- 16:15with children in from the schools
- 16:17from the Community,
- 16:18mental health settings and I underline
- 16:20that all the parents were engaged
- 16:23but only as Co agents of change.
- 16:25So panels were not.
- 16:27A important part of this story,
- 16:29and in case people are wondering about
- 16:31that since I am so interested in parents.
- 16:35And so,
- 16:36for example,
- 16:36this was a prototype,
- 16:38so we developed different flowcharts
- 16:40that different children and you
- 16:42know this might be for one child,
- 16:44but for some children it might
- 16:46be a different module of what
- 16:48might be needed for anxiety,
- 16:50and it was actually very very cool,
- 16:53and I think that's a large reason for
- 16:55the success of this effectiveness.
- 16:57Trial was because of the systematic
- 17:00way that we identified and stratified.
- 17:03Youth and. It identified.
- 17:09I'm using a two faced ratification
- 17:11process an it's it's again.
- 17:13This is more than I want
- 17:15people to get to get into,
- 17:17but I do think an important
- 17:20part of an effectiveness trial
- 17:21is being able to identify and
- 17:23make sure you've stratifying the
- 17:25youth so you know which module,
- 17:28which dose which sequence to be giving.
- 17:30That,
- 17:31I believe was a big reason for the success
- 17:34of this because the data were actually
- 17:36really very very good, but Mau was.
- 17:39With management as usual,
- 17:41MMM is mind my mind and this this
- 17:43strength and difficulty question here.
- 17:46This is the main go to measure in child
- 17:49psychology and psychiatry in Europe.
- 17:51We don't use it as much in the states,
- 17:54but it is the go to measures
- 17:57in Europe and so sure enough we
- 18:00found that the the the people got
- 18:03getting the evidence based modules.
- 18:06Significantly improved overtime,
- 18:08including over the 26 follow up
- 18:11compared to the control condition.
- 18:15And this Additionally.
- 18:19The teachers confirm this.
- 18:21The children confirmed this with the
- 18:23with their versions of the SDQ and there
- 18:25were no adverse effects and currently
- 18:28we're doing a cost effectiveness study
- 18:30Anwyl doing long term follow up.
- 18:34So let me pause here for now with
- 18:36the clinical takeaways that there
- 18:38is international consensus and
- 18:40phenotyping pediatric anxiety disorders,
- 18:42child and parent rating scales are
- 18:44generally good and excellent across
- 18:47a wide range of cycle metrics.
- 18:49CBT is efficacious about 60% limit,
- 18:51but we do need to enhance,
- 18:53and that's what we'll be talking about.
- 18:56They were predictors of poor CBT outcome,
- 18:58which is severe anxiety,
- 19:00especially adolescence.
- 19:00Social anxiety,
- 19:01an we can successfully disseminate
- 19:03CBT for anxiety in and,
- 19:05and this has been shown
- 19:06through effectiveness trials.
- 19:08So this so far I've been giving
- 19:10some good news, I think.
- 19:12But now I think I need to pause
- 19:15for some bad news,
- 19:16and this is the bad news in 2000.
- 19:19Three Amando Pena was a graduate
- 19:21student at the time.
- 19:23He's now an associate professor
- 19:24at Arizona State,
- 19:25and this is a paper where we
- 19:27did this paper and you can see
- 19:30this table from this paper,
- 19:31and this was looking at the proportion
- 19:34of Hispanic Latinos in anxiety trials.
- 19:36And if you look at this list in 2003,
- 19:38you see a Nah,
- 19:40Nah Nah Nah tool is percent tooth
- 19:42done and then you see a 37% and 46%
- 19:45in the rest of none and those 237 and
- 19:4846 were actually two of our trials.
- 19:51Those in 2003 and 2021 in
- 19:53this review that came out,
- 19:55which I'll actually be talking about again.
- 19:58Three out of 11 CBT plus pound studies.
- 20:01So this was no longer CBT.
- 20:03This CBT plus parent,
- 20:04but still three out of 11 did not
- 20:07report ethno racial composition.
- 20:09One study did not report specific
- 20:11so this is that this is all
- 20:13groups and actress Hispanics.
- 20:15Most studies reported less than 10%.
- 20:18With the exception of one study,
- 20:20and in this case,
- 20:21since this was a CBT plus payment,
- 20:24they sight out of 2009 and I I guess
- 20:27I need to say I didn't tell you this
- 20:30after Albany everyone to Miami.
- 20:32So this is these with Miami samples.
- 20:35And so this explains the very nice
- 20:37representation we had of Hispanics,
- 20:39but it's it's.
- 20:40It's like not OK frankly that in 2021 our
- 20:44participation rates of other groups is is.
- 20:47You know abysmal and it's not acceptable,
- 20:49and I'm hoping it.
- 20:50While I'm here and this is
- 20:52actually a large reason why I I do
- 20:55continue my collaborations,
- 20:56this the attention training study that
- 20:58I'll talk about is a two side study
- 21:01that it still includes my affiliation.
- 21:03When I was in Miami because it's,
- 21:06you know,
- 21:06it's it's an important part of our
- 21:09work to try to undo to get these
- 21:11samples and understand how our
- 21:13treatments work with diverse samples.
- 21:18OK, so now parents, how do we involve
- 21:21parents to improve CBT outcomes?
- 21:23Look 12 to 14 sessions.
- 21:25Two is to have almost 60% improving.
- 21:28That's really, really good.
- 21:29But you know we need to do better.
- 21:33The durability needs to be better.
- 21:35Wingan parents certainly make a
- 21:37great deal of sense to how to try
- 21:41to think about their role can be.
- 21:43Now, Interestingly,
- 21:44I told you 94 Kendall did the
- 21:46first individual study in 99.
- 21:48We did the first group and
- 21:51the group CBT study in 1996.
- 21:53In the bottom you see the Barrett study,
- 21:56the first parent plus CBT versus CBT
- 21:59study was done only in night was done
- 22:02around the same time that we did hours 1996.
- 22:06But I I share that with you
- 22:08because in 1996 Bill Katinas,
- 22:09my friend and collaborator for
- 22:11my 22 years when I was in Miami,
- 22:14we wrote this book for clinicians
- 22:15and it was called anxiety and phobic
- 22:18disorders of pragmatic approach.
- 22:19And we and what we did there in that book.
- 22:23We laid out what and we will kind of
- 22:25making this up because the you know
- 22:28nobody had been doing anything with
- 22:30parents yet at the time and we came up
- 22:33with this idea of the protection trap.
- 22:35We have a few.
- 22:36You know,
- 22:37like maybe half a chapter on
- 22:39the protection trap and we talk
- 22:41about how children of vote with
- 22:43anxiety avoid they show distress.
- 22:45The parents then behave.
- 22:46By maintaining this.
- 22:47They might say you don't want
- 22:49to go to school.
- 22:50You don't need to go to school,
- 22:52you can stay home.
- 22:53This brings about relief and
- 22:55it's a child feels protected.
- 22:57The parents felt protects good that
- 22:59they're protecting their child and it.
- 23:00And then it's continued to be a cycle.
- 23:03It's a protection trap.
- 23:04It's a negative reinforcement trap,
- 23:06and that's I.
- 23:07Is a model that continues to,
- 23:09you know,
- 23:09be used a lot and it's really
- 23:11holds clinically a great deal
- 23:13and and we actually then talked
- 23:15about the treatment implications.
- 23:17We talked about it in that book and
- 23:19we also talked about it in chapters
- 23:21and we also wrote this article theory
- 23:24and trial psychosocial treatment research.
- 23:27Have it or had a pragmatic alternative
- 23:29and we called it a pragmatic
- 23:31because we would take away is look.
- 23:33There are many ways you probably
- 23:36can work with children.
- 23:37And we can.
- 23:38And we called it a transfer of control model.
- 23:42I actually prefer to call it
- 23:44more generalization model now,
- 23:45but but the idea was that if you
- 23:47are an evidence based clinician,
- 23:49you know what treatments you know,
- 23:51what the you know.
- 23:53What are the procedures and the
- 23:55methods that have the strongest
- 23:56evidence and your job as a clinician
- 23:59is to generalize this to children,
- 24:01generalize this information
- 24:02and knowledge to parents,
- 24:04and then there are different
- 24:05ways you can do it and this.
- 24:08Clinical trial in 1999 was a
- 24:10dismantling trial because we basically
- 24:11dismantled the transfer of control.
- 24:13If you see the full transfer of control
- 24:16that's working, therapist to parents,
- 24:18the children and the therapist is
- 24:21still with the child so you do CBT
- 24:23and you do some work with parents.
- 24:25And that's what most of what we do.
- 24:28That's the full transfer of control in
- 24:30this particular trial, though we actually.
- 24:33Dismantled and we did mainly Trump exposure,
- 24:36is exposure is the main procedure
- 24:38for producing.
- 24:39But this is a phobia study,
- 24:41particularly with phobias.
- 24:43And then we also trained parents.
- 24:45In the other arm pound reinforcement
- 24:47training in in the article,
- 24:49we called the Contingency Management,
- 24:50but we compared these two models that
- 24:53the results are not as important as the
- 24:55model because I'm going to put this.
- 24:57But this is the way we think
- 24:59about working with children,
- 25:01children and parents.
- 25:01Just how you work with parents.
- 25:03But in terms of the results.
- 25:07We actually found that with phobias.
- 25:09This is a behavior observation
- 25:11that all the children in all the
- 25:13in both of arms showed improvement.
- 25:15There were no significant differences,
- 25:17which is kind of not,
- 25:19which is sort of what we kind of.
- 25:21Frankly, we're really.
- 25:22We're really more interested in seeing
- 25:24clinically and theoretically of this model.
- 25:26Hope you can work, and we found that yeah,
- 25:29you could work with both of these.
- 25:32You can do these.
- 25:33This type of approach and what
- 25:35I found really interesting,
- 25:36actually, is that was in 1999.
- 25:39In 2014 and I did contribute data to
- 25:42this data after this meta analysis,
- 25:45disciplinary men analysis as you
- 25:46see it is a long list of anxiety
- 25:50researchers who contributed data.
- 25:52But what's really interesting in
- 25:54this meta analysis was that they.
- 25:57They said that.
- 26:00The conclusion is they,
- 26:01like they looked at all the different
- 26:03ways parents researchers are using
- 26:05parents and they actually came up with hey,
- 26:08the way that most people are
- 26:10working with parents.
- 26:11They're actually doing
- 26:12contingency management,
- 26:13so let's call it reinforcement training.
- 26:15Although they also called it when I
- 26:17called in my article continues to
- 26:19management or a full transfer of control,
- 26:21and they found that CBT for
- 26:23entries children is efficacious,
- 26:25with or without and without
- 26:26pound involvement.
- 26:27But if you want to look up a durability.
- 26:30Some form of parent involvement.
- 26:33Probably with some kind of reinforcement
- 26:36training and some type of strong parent
- 26:40transfer is the strongest evidence,
- 26:42so I I found that kind of reaffirming,
- 26:46frankly to see that however.
- 26:49It still doesn't tell us what are the
- 26:52specific so specific is so important.
- 26:54It's in red on my slide.
- 26:56What are the specific payment
- 26:58mechanisms that ought to be contained
- 27:01in a transfer of control approach?
- 27:03Which is they figure that you see the
- 27:05therapist to pound the child and the
- 27:07therapist child two enhanced CBT alone.
- 27:09What is what should be done
- 27:11and you might say why?
- 27:12What's hard about that?
- 27:13Of course it's going to be X so it's close.
- 27:16It's going to be why,
- 27:17but actually this table I I made up
- 27:20this table but it comes I didn't make
- 27:22it up but it comes from looking at all
- 27:24the literatures or the meta analysis.
- 27:26These are all the different mechanisms
- 27:29that people have looked at and
- 27:31have targeted in their treatment
- 27:33and you could look at the list.
- 27:35An I'm calling it mechanisms
- 27:36in my presentation.
- 27:37An eye image calls it targets.
- 27:39If you're a statistician,
- 27:41you call it mediators,
- 27:42and I actually I often call
- 27:44it mediators as well.
- 27:45If your clinician,
- 27:46you might call a component,
- 27:48but the bottom line is in a
- 27:50course these studies that mainly
- 27:51they're vaguely defined often,
- 27:53they're often compounded together,
- 27:54so somebody might say, oh,
- 27:56I'm, I'm doing acceptance.
- 27:57In fact, actually,
- 27:58let me give the example I've done.
- 28:01I said,
- 28:01oh I'm going to improve the
- 28:03parent child relationship.
- 28:04But then what I actually did was I
- 28:07had a couple of things in there.
- 28:10It was a mish mosh so these are lessons
- 28:12learned but people continue to do that.
- 28:14It's a big conundrum for researcher
- 28:16'cause you don't know well as I show it.
- 28:18What do you do?
- 28:19What do you study?
- 28:21How do you operationalize it?
- 28:22And clinically,
- 28:22clinicians really don't know,
- 28:24like, what do I do with the pants?
- 28:26It still is a big conundrum,
- 28:27but I also want to say
- 28:30it's not just the research.
- 28:32It is difficult and challenging
- 28:34in specially in 12 to 14
- 28:36sessions to think that we can.
- 28:41You know, adequately, fully durably,
- 28:43change payment behavior in a very
- 28:45complicated dynamic between an
- 28:47anxious child and the parents.
- 28:48This is very, very challenging.
- 28:50It goes beyond the research.
- 28:52It goes beyond, you know,
- 28:54the challenges of the of the dynamics
- 28:57that have existing in these families.
- 29:00To make this more concrete,
- 29:02let me just stop for a moment,
- 29:04and for those of you,
- 29:05this is the dilemma.
- 29:06Is like 1/2 budget.
- 29:07It's like this when you want
- 29:09to make a hot fudge sundae.
- 29:11You know you need the ice cream,
- 29:13so if you want to do CBT plus parents,
- 29:15you know you need the CBT which
- 29:17is the ice cream.
- 29:19But the problem is with CBT plus pounds
- 29:21we don't know what the hot fudge is.
- 29:23You know, and some people have
- 29:25identified some of the hot fudge,
- 29:27but some people think it's the
- 29:29cherry in that Remy is actually a
- 29:31very small part of the variance to
- 29:33a hot fudge sundae and a whip cream
- 29:35is more important than the cherry,
- 29:37but it's still not as much of
- 29:39the variance is the hot fudge.
- 29:40And then you even have some possibilities,
- 29:42which I think is the case that you
- 29:45certainly don't want to put salami
- 29:46or Pickles in your hot fudge sundae.
- 29:48And some of those payment components in
- 29:51some ways could be an analog to this,
- 29:53so the dilemma were faces.
- 29:54What is going to?
- 29:56Account for some as much variance
- 29:58can contribute as much as we can to
- 30:00enhancing CBT. What is the hot fudge?
- 30:05Now I came in 2013,
- 30:06but my when I was interviewed for my.
- 30:10Well,
- 30:11this was slide was from my 2011
- 30:13Yelp presentation.
- 30:14Although I didn't say for my
- 30:16Yelp presentation 2011,
- 30:18but the rest of it was.
- 30:20This is what I said in 2011.
- 30:22No supportive evidence for enhanced effects.
- 30:25Is an the studies measure anxiety
- 30:28outcome only and it's rare to even even
- 30:31though people are interested in panels,
- 30:33people don't even include payment measures.
- 30:36That's for 2011.
- 30:382021 that's a man made and Elton and
- 30:40study I gave you when I look when I
- 30:43came across this paper and this is
- 30:45either aging myself or show up well.
- 30:48I'm sure it's aging myself,
- 30:49but it's also when I saw it.
- 30:51I just said man 10 years after
- 30:53this is deja vu all over again.
- 30:55So I'm a rock person.
- 30:57So this is the album continues
- 30:59after and this is Cosby.
- 31:00Stills Nash and young deja
- 31:02Vu because in 2021.
- 31:04The words correspond with the figures.
- 31:07This is a direct quote.
- 31:09CBT and parents did not confer
- 31:11advantage over individual CBT.
- 31:13Only six of,
- 31:14so that's what the first figures are.
- 31:17The figures at the bottom,
- 31:19the standard elite defense means
- 31:21that's the second correspond
- 31:23to the second bullet.
- 31:24Only 6 of 11 trials even included a
- 31:27parent and family measure at pre and post,
- 31:31not even a follow up post and when measured.
- 31:35No significant differences found.
- 31:36So even when you try to
- 31:39target something,
- 31:40it didn't make a difference.
- 31:42The parent measures didn't even change,
- 31:44and nobody even looked at.
- 31:45Whether not it is so.
- 31:47It matters if they if they
- 31:49change those outcomes.
- 31:50But they even serve any type of
- 31:52mechanism or mediational role.
- 31:54And the only study of the six at
- 31:56the bottom was hours in 2009.
- 32:07So if we could just do
- 32:09our science with cartoons.
- 32:11Things would be so easy because
- 32:13these two cartoons are basically
- 32:15going to summarize now.
- 32:17What three clinical trials?
- 32:19So over 15 years of clinical trials research
- 32:24has taught me and I hope the field.
- 32:27And the first one is they act like
- 32:30they own me and this is a depiction
- 32:32of what I will show is what I'm
- 32:35beginning to think is one of the most
- 32:38important payment mechanism which
- 32:39is payment psychological control.
- 32:40The one at the bottom is that negative
- 32:43reinforcement trap that I talked about.
- 32:45It's the protection trap. This is great.
- 32:47I'll have to wake up crying in the
- 32:49middle of the night more often.
- 32:51OK, so these are.
- 32:53That was almost.
- 32:57So I'm going to show you now quickly,
- 33:00quickly, but you know that
- 33:01is relatively quickly.
- 33:02I'm going to go through three trials
- 33:05that we did and one to the numbers in.
- 33:08The parentheses showed the trials
- 33:10and they showed the hypothesis.
- 33:12So there are three trials.
- 33:13So the uh, so for example,
- 33:16the first one is in the first two trials.
- 33:19If we try to target and improve
- 33:21parent child relationship,
- 33:22that will be associated with pediatric
- 33:25anxiety with suction and the.
- 33:263rd, the second one is site control
- 33:28and we targeted that in three
- 33:30trials with the hypothesis that if
- 33:32we reduce psychological control
- 33:34it with the associated pediatric,
- 33:36and this was a full transfer
- 33:38of control model in our work,
- 33:40the therapist worked with the
- 33:42parents and the children we did CBT,
- 33:44but we also did some type of these
- 33:46types of approaches with the pants.
- 33:51Clinically step back clinically,
- 33:53because and I'm sorry I want to go back
- 33:56so you see the astrex by this site
- 33:58control in the negative reinforcement.
- 34:01So across these three trials,
- 34:02this is the cartoon.
- 34:04Again, these are the mechanisms
- 34:06and the mediators that I'm.
- 34:09You know, feeling more and more comfortable
- 34:12is where we need to put our resources into.
- 34:16So clinically. Of course, the free trials.
- 34:19How did we do that?
- 34:20Well, we work with the kids and
- 34:22the parents and we would have
- 34:23them make a list with together.
- 34:25How does how does the pan and get too
- 34:27much involved with my child and how
- 34:29do I let my child do it on their own?
- 34:32And you can see there.
- 34:34Some examples.
- 34:37Like the third one is a specific
- 34:39field example show my diploma,
- 34:40but you know a lot of the parents would
- 34:42say that the kids stop acting like a baby.
- 34:44Or why can't you be more like your
- 34:46little brother?
- 34:47So we would, you know,
- 34:48talk to them about.
- 34:49Well, I can tell my child I'm confident
- 34:51they can handle it in their own,
- 34:52so this would be ways we would target
- 34:55this reduction of site control.
- 34:56In terms of negative reinforcement,
- 34:58which we which remember,
- 34:59I did this in 1999,
- 35:00but we did it again in our third
- 35:02trial more systematically,
- 35:04and this is how we would do it.
- 35:06There we give you know how does
- 35:08my child try to stay away.
- 35:10Trial tries is the cartoon,
- 35:11my child twice about his parents
- 35:13room at night to sleep with them?
- 35:15But what can the mom do?
- 35:17Do not allow the child to sleep
- 35:19with the pounds at night?
- 35:22And you can look there first.
- 35:24Some other examples.
- 35:31So sweet dismantling files an in 5 minutes,
- 35:34but this is basically this is
- 35:36what they all had in common.
- 35:39They were clinic referred participants.
- 35:43Randomize the majority of
- 35:44the participants on mothers,
- 35:45as mothers are the ones who are more likely
- 35:49to bring their children in for the treatment.
- 35:53In the children and the
- 35:54parents were seen together.
- 35:55As I said, it was a full transfer of control.
- 35:59We did CBT with the children,
- 36:00but we also worked on these parenting
- 36:03components which you'll see in.
- 36:04I'll be clear in the next few slides.
- 36:06So in trial one we compared CBT
- 36:08and parents with CBT and because
- 36:10things weren't the way we hoped,
- 36:12we said you know in the second trial
- 36:14we said you know let's not have any
- 36:17parents involved in the second trial.
- 36:19Let's just do group content behavior therapy.
- 36:21I also really love coupons
- 36:23if behavior therapy,
- 36:24as it was one of my.
- 36:26Earlier trials an and
- 36:27let's just do that and and.
- 36:29It's also the first time CBT plus
- 36:32pounds has even been compared to GCBT,
- 36:34so let's compare that.
- 36:36And then the third trial
- 36:38is what I call a deer,
- 36:40dismantling trials where we compared
- 36:42to CBT's and parents versus CBT and
- 36:45what's important in all of these
- 36:47trials is we measured the hypothesize
- 36:49payment mechanism in all the arms.
- 36:52So even in CPT we measured
- 36:54the parent variables with.
- 36:55Remember that 2021 I said
- 36:57six trials only has done it.
- 37:00So we made a point.
- 37:01I mean,
- 37:02if you're going to study payment mechanisms,
- 37:05you need to measure payment valuables.
- 37:07And as part of your assessment.
- 37:09So we did that.
- 37:10And this was the assessment schedule.
- 37:14At least for today's presentation,
- 37:15we actually have more data
- 37:17than that we collected.
- 37:19Now these analysis and these
- 37:21models get really complicated,
- 37:22and so this is a depiction of one of
- 37:25the models in one of our articles.
- 37:28And clearly I'm not going to present
- 37:31the results today with these SCM models.
- 37:33So for today's presentations I'm
- 37:35going to present simple means,
- 37:37but I do want to just let a
- 37:40shout out to call it Mount.
- 37:42It was my who is here and yell with me.
- 37:46But was we?
- 37:47She trained with me at FIU and Jasmine.
- 37:50Also, at a trainee of mine
- 37:52at FIU who sold now it,
- 37:54if I you running the attention
- 37:56training study there with a colleague
- 37:59and Jim jacket is my friend and
- 38:01who I've known since my old many
- 38:03days and he was with me in Albany.
- 38:05And if I,
- 38:07you and now at NYU and I share this
- 38:09with you because like I I actually
- 38:12love SCM modeling because it makes us
- 38:15as a team said, think about the park,
- 38:17the proximal mechanism,
- 38:18the distal, the moderate Ersan.
- 38:20Really try to.
- 38:21Think about them in a very thoughtful way,
- 38:24and then the SCM modeling just
- 38:26becomes a template from the
- 38:27conceptual model that we worked on.
- 38:30So I really love this and the
- 38:32reason I also want to emphasize
- 38:34the last point is also important.
- 38:36Most treatment studies,
- 38:37if they even have a mediator or mechanism,
- 38:40they have one media,
- 38:41one mechanism you will see how
- 38:43we have multiple mediators,
- 38:45which makes things even more complicated,
- 38:47which I can't even go there about how
- 38:50the media does affect the mediators.
- 38:52But I think the point is that you know,
- 38:56we really try to have a a picture
- 38:59that fits clinically and that
- 39:01has practical implications for
- 39:04clinical translation.
- 39:08So the first two trials.
- 39:11I also I also say when we
- 39:13have those multiple mediators,
- 39:15our requires large sample sizes so
- 39:17you will see our across all three
- 39:19trials for a single site study out of
- 39:22sample sizes are quite nice and give
- 39:25us sufficient power to look at these
- 39:27mediation and moderating variables.
- 39:29So in the first trial we did when
- 39:31I told you CBT plus payments and
- 39:34then the second one was compared
- 39:36to the group the group.
- 39:39Don't pay attention, even though
- 39:40it's so interesting and I love it,
- 39:43but I don't have time to talk about the
- 39:46mechanisms of group CBT, but we are.
- 39:48I think it's fascinating,
- 39:50so that's for another time, another place.
- 39:52Because today I'm focusing on the
- 39:55CBT plus parents and what I mainly
- 39:57want to show you is that in both
- 40:00of these trials we found that site
- 40:02control in both of these trials
- 40:04was associated with a change in the
- 40:07anxiety outcome and an and it actually.
- 40:09You know hasn't been shown before.
- 40:11Obviously you saw from my set up here,
- 40:13so this was nice to see this in
- 40:17two different trials.
- 40:18But what we also found an not
- 40:22surprising what I showed you before.
- 40:25Both interventions were
- 40:26similarly efficacious.
- 40:27There were no significant differences.
- 40:28It's great that you can improve,
- 40:30but we were hoping to enhance
- 40:32and we didn't enhance.
- 40:34And this is this came through
- 40:35not just with the rating scales,
- 40:38but with the other measures.
- 40:41So this was a pretty robust pattern,
- 40:43but it fits what I showed you.
- 40:47So what we learned except
- 40:49bullet one we didn't learn.
- 40:50We already knew this anxiety significantly
- 40:52reduce in CBT and CBT and parents.
- 40:55But there are no significant differences.
- 40:57Anxiety is suddenly reduced
- 40:58and this was a first.
- 41:00This was a first 'cause nobody
- 41:02would ever compared parents
- 41:03with CPT and pans in the group.
- 41:05It was nice to know that both are reducing
- 41:09anxiety and you could do both of them,
- 41:11they're interchangeable.
- 41:13And but we also found and this is the
- 41:16important thing here that changes
- 41:18in pain control were associated
- 41:19with changes in pediatric anxiety.
- 41:22It does suggest that maybe of all
- 41:24those mechanisms, Pam inside control.
- 41:25But this is this idea that if you
- 41:28are reducing site controlled of the
- 41:30parents enhancing child autonomy,
- 41:32it will encourage the trial to
- 41:34be more likely to do the things
- 41:36they need to do in anxiety.
- 41:38That's the clinical way to
- 41:40think about why side control.
- 41:42If you are a parent telling you kid you know.
- 41:45This, you know, don't be a baby.
- 41:47That's not going to give the
- 41:49child a feeling of autonomy or
- 41:51granting autonomy so clinically.
- 41:53It certainly makes a lot of
- 41:55sense and fits with you.
- 41:57Know,
- 41:57many theories of side control
- 41:59dating back to the 1970s,
- 42:01so.
- 42:07In the third trial.
- 42:09Though you know I wanted to go deeper,
- 42:12and so we dismantled.
- 42:14We dismantled CBT plus parents which
- 42:18had never been done because what do you
- 42:21need to do in CBT plus parents an I
- 42:25because of my 1999 trial reinforcement
- 42:27the important of the protection
- 42:29trap we dismantled CBT plus parents.
- 42:32But we also dismantled CBT plus Pam and
- 42:35Reinforcement where we trained parents
- 42:38to increase their positive reinforcement,
- 42:40decrease negative reinforcement the
- 42:42comparator the CBT and here we.
- 42:45I wasn't giving up on the relationship,
- 42:47but I told you I thought we were
- 42:49doing too much junk in that.
- 42:51I mean, I should say junk,
- 42:53but I thought why isn't this working?
- 42:55How could this not so this time we
- 42:58dismantled it more carefully and we made
- 43:00it more careful of really distilled
- 43:03site control an we improved acceptance like?
- 43:06I'm not going to have a slide on that,
- 43:09but since it hasn't been working,
- 43:11I'm not.
- 43:12I don't have the slide on that because
- 43:14what we found here as a meat as
- 43:17mechanism doesn't associated with change.
- 43:19The decrease in negative reinforcement
- 43:21was associated with anxiety in production
- 43:24and again side control decrease was
- 43:26associated with child anxiety improvement.
- 43:28And what if I was there in the room?
- 43:32You'd see me like jumping and
- 43:34being happy because I'm very,
- 43:36very happy about these findings.
- 43:38It's actually it will be published
- 43:40any day now.
- 43:41And kind of this also in
- 43:44clinical psychological science,
- 43:45the name of the articles is
- 43:47training parents and reinforcement
- 43:49skills or relationships.
- 43:50Trip skills enhance individual use.
- 43:52CBT for anxiety outcome
- 43:53specificity and mediation.
- 43:55And you don't.
- 43:56I don't know anybody who puts
- 43:58the title of an article.
- 44:00If the answer is no,
- 44:02so the an we were this we've showed
- 44:05here that both of these very
- 44:08distilled concrete CPT plus parents
- 44:10across the measures were showing
- 44:12to be significantly enhancing CBT.
- 44:15This is also true in our
- 44:18diagnostic recovery rates.
- 44:19So this is the,
- 44:21you know something very exciting.
- 44:23Frankly,
- 44:23at least for people who are trying to
- 44:27figure out what to do with parents.
- 44:30Even more exciting is this.
- 44:32The first time we showed that if you
- 44:35do this in a really concrete way,
- 44:38you can actually show that what you talk it,
- 44:41it changed an and that it so when we
- 44:44worked with reducing negative reinforcement.
- 44:48Our parents told us that yes,
- 44:50it was reduced in individual CPT.
- 44:52We didn't train it, but past studies.
- 44:54Usually anything.
- 44:55Nothing changes.
- 44:56So and this was true also in
- 44:58the control scale.
- 44:59So we were happy about this too.
- 45:04So right now what we've learned
- 45:07so far from these three trials
- 45:09is if we do two carefully, very.
- 45:41Very qualitative methods with
- 45:42families and fair therapists,
- 45:44and we're going to try to develop
- 45:46something so it's always with them.
- 45:49A way of getting parents to always
- 45:51use these kinds of methods.
- 45:53And what do you do when you're
- 45:56stuck with the idea of we can
- 45:58maybe get more stronger effects?
- 46:00More durable effects if we can
- 46:02really make this more, you know,
- 46:05part of people's everyday lives.
- 46:07And so with you know,
- 46:08these are the steps that involved
- 46:11the participatory methods.
- 46:12The proof of concept.
- 46:13Then get some plima Neri effects,
- 46:15and then of course the next step is
- 46:17a step which is the big challenges
- 46:20to augmented and dismantle it and
- 46:22see you know it really improves.
- 46:26Really quickly, because some of you
- 46:29may be familiar with Eli Lebowitz,
- 46:32my my collaborator and at the Anxiety
- 46:35program and he has developed a very
- 46:39innovative intervention and it's a
- 46:41transfer of control therapist dependent.
- 46:44No child, no children at all involved,
- 46:47and I'm just taking this little
- 46:49detour to mention it because I'm.
- 46:52You know he we showed that it has.
- 46:55We compare this to CBT.
- 46:57His program is called Space Supportive
- 47:00Parenting for anxious childhood emotions
- 47:03and what we found was that both.
- 47:06Interventions using a non inferiority trial,
- 47:08both produced in equivalent affect,
- 47:10so this was very this is Eli scale.
- 47:13What I I should mention when I came
- 47:16I know he put together this K award
- 47:19now and this is we now have a nice
- 47:2361 or 33 and Hillary is Hillary.
- 47:26Bloomberg is a call investigator
- 47:28on this along with me and Ellen G
- 47:31at over in psychology is the copii
- 47:34with Eli on this and we are now
- 47:37studying CPT versus parenting.
- 47:38We're looking at if these findings
- 47:40replicate and we're also looking
- 47:42at the brain mechanism underlying
- 47:43these two interventions because
- 47:45it's kind of interesting.
- 47:46This one is just with child when
- 47:49it's just the parents and looking
- 47:51at how the change the child's brain
- 47:53may be impacted by this and then
- 47:55the next thing after we hopefully
- 47:57replicate these findings,
- 47:58that space is as efficacious as CBT.
- 48:01The next thing, of course,
- 48:02will be to try to think about
- 48:05augmenting space with CBT,
- 48:06or or maybe even dismantling it,
- 48:08but.
- 48:08This is the first stage an I
- 48:10think it's really exciting work
- 48:12because it's only with parents.
- 48:14No child work at all.
- 48:19OK, so that's the work I do.
- 48:22Want to spend a little time also
- 48:25talking about the other area
- 48:27that we're trying to augment CBT,
- 48:30and that's with attention.
- 48:31Retraining if you're prone to anxiety.
- 48:34If you look at that stimulus on your screen,
- 48:37your attention will go
- 48:39talk that threatening face.
- 48:41This is what that first bullet says.
- 48:44Anxious children, adolescents,
- 48:45and adults so significantly greater
- 48:47attention capture to threatening stimuli.
- 48:49And this has been associated with
- 48:52friends to amygdala dysfunction.
- 48:53The translation clinically is trained.
- 48:55The brain, you know,
- 48:57use it implicit learning procedures
- 48:59to modify that attention capture.
- 49:01That's why it's been called attention
- 49:04bias modification training.
- 49:06And there's evidence for that an I
- 49:09encourage Lazzaro for Yair behind
- 49:11did excellent with you in the
- 49:13recent biological psychiatry that
- 49:15was devoted to pediatric anxiety.
- 49:17All the articles were fabulous,
- 49:19I thought,
- 49:20and your ears meta analysis showed
- 49:23medium effect sizes in child trials,
- 49:25and he also talks about the biological
- 49:29underpinnings for attention training.
- 49:31So more specifically,
- 49:32and here are my colleagues.
- 49:34Actually,
- 49:35your ear is a collaborator and
- 49:37Annie Pine at NIH is a collaborator,
- 49:39and Jeremy Pettit at FIU is another
- 49:42collaborator.
- 49:42And basically here's this child
- 49:45sits in front of the computer.
- 49:48And she's shown this Lee stimuli and
- 49:50basically the plus sign is always
- 49:53placed in the experimental condition
- 49:55the what's called the attention bias
- 49:58condition modification condition.
- 49:59It's always plus by the neutral
- 50:02100% of the trial and it there
- 50:05really quick milliseconds.
- 50:06So basically.
- 50:07And she's told whenever you see that
- 50:10plus sign plus press your mouse
- 50:12so that implicitly training the
- 50:14brain to look at that neutral face,
- 50:17the control condition.
- 50:18Is it appears randomly it's not anywhere,
- 50:21but there's still attention and it's funny.
- 50:23It's called an attention control
- 50:24condition because it's as you
- 50:26will hear in a moment.
- 50:27But I'm just going to say it now.
- 50:30Attention control condition is actually
- 50:32probably in attention control condition.
- 50:34Because you are controlling your attention,
- 50:37so you'll see in a moment
- 50:39why that's important.
- 50:40And the nice thing about this,
- 50:42it's really short and sweet.
- 50:448 sessions over 4 weeks,
- 50:4620 minutes and 160 trials each session.
- 50:48I mean super fast.
- 50:51So if requires little effort and motivation,
- 50:54little need for a therapist to be involved.
- 50:57It's computer base and kids you
- 50:59know into computers and it's more
- 51:01accessible in CBT and on medication.
- 51:05So given what I just said,
- 51:07we actually did an open trial on this just
- 51:10to see if how it would work in a stepped care
- 51:13approach and and a cost effectiveness trial.
- 51:16So here we gave all kids coming to
- 51:18the clinic and this is this.
- 51:20Is the clinic actually in Miami and 124
- 51:23kids came through and they got four weeks.
- 51:26Just what I told you of attention,
- 51:28retraining and after the full weeks
- 51:30we said to them into open trial.
- 51:32We said do you want to
- 51:34continue and not to continue?
- 51:3660% said I'm good,
- 51:37I don't need anymore and we assess them,
- 51:39assess them thoroughly with the
- 51:41methods I gave you in the beginning.
- 51:4379% were improved and they were done.
- 51:46Both, but 45 kids.
- 51:47Of these 120 of the initial said no.
- 51:50Actually I want CBT so they found
- 51:53to be 91% much improved or very
- 51:56much improved after Step 2 where
- 51:58we also had a health economist
- 52:01working on these papers with us and
- 52:03you could see there that if these
- 52:06kids had just gotten full CBT,
- 52:08they didn't get the step care.
- 52:10They took out full CBT.
- 52:13It would have been 13 hours when they did
- 52:17it in the way we did it in the study,
- 52:20it took 6.7 hours,
- 52:21so it's almost a 50% reduction in
- 52:24time and then also computed was
- 52:26if they got the full CPT it would
- 52:29have been almost 800 bucks here
- 52:31with the step care it cost 433 so
- 52:33it was a 50% overall cost savings.
- 52:35This is important information because I do.
- 52:39In another thing I hope to do is
- 52:41after we do the next trial with
- 52:43their crony doing I I really do
- 52:45want to do an effectiveness trial
- 52:47similar to what we did in Denmark
- 52:49using the same type of approach in
- 52:51identifying and stratifying the kids.
- 52:52So this is really important
- 52:54information whenever you want to
- 52:56do an effectiveness trial to show
- 52:57that you got these kind of data.
- 53:03The other thing that we did that was
- 53:06very interesting is I told you that
- 53:09about 60% of kids will improve with CBT,
- 53:11but you got about, you know 40% that might.
- 53:14So you saw the large ends that we had
- 53:18those launch ends, and so we actually
- 53:20wrote a grant and all 34 and an an.
- 53:23We said, you know we're going to have
- 53:27we're running these launch trials
- 53:29with looking at CBT and parents.
- 53:32We're going to have a bunch of
- 53:34kids who are going to need help.
- 53:37How quit letting us see if we
- 53:39can do this attention,
- 53:41retraining and see if this works.
- 53:43And sure enough, we did it and we found.
- 53:46So these are kids at post and
- 53:48follow up who still met diagnosis.
- 53:51After they got a full course of CBT an
- 53:54we then did the attention retraining,
- 53:57you know those four weeks and we
- 53:59found that all these kids and it's 64.
- 54:02But keep in mind these we don't
- 54:05want a million kids 'cause these
- 54:07are kids who were in our trial,
- 54:10so we don't want to have too
- 54:12many failed kids but these failed
- 54:14CBT kids or CBT resistant,
- 54:1650% recovered at the post and
- 54:1858% of follow up and there were
- 54:22significant differences.
- 54:23In
- 54:26anxiety. But there were no significant
- 54:31difference. But this is the rub.
- 54:33The rub is whether they were in the attention
- 54:36bias condition or the attention control.
- 54:38The control control kids
- 54:40improved across the board.
- 54:41We didn't expect this,
- 54:43but this is becoming more of a finding
- 54:46now and I don't have time unfortunately.
- 54:48But down below you see another
- 54:51little eyes and say a little,
- 54:53but we did another trial.
- 54:55This is actually Marielen
- 54:57net ski over Tel Aviv.
- 54:59Supervised by your ear,
- 55:01and this was also publishing
- 55:03clinical psych science webdrive
- 55:05symptom reduction in attention,
- 55:07bias, modification, treatment,
- 55:09vandalized, controlled experiment.
- 55:10And this study is supporting the suggestion
- 55:14that both the kids are getting better.
- 55:17In both of these arms,
- 55:20and some suggestion that it may
- 55:22not be the training an bias,
- 55:25the modification bias,
- 55:26but the training and attention control,
- 55:29helping kids to better
- 55:31modulate their attention,
- 55:32we now have with FIU and ongoing.
- 55:35Now I don't even I don't even call it
- 55:38attention bias modification training anymore.
- 55:41Now we'll just call it attention be training.
- 55:45It's an efficacy confirmatory trial.
- 55:48We have an alternative competitor
- 55:50we have because it's with Miami.
- 55:52We've launched diverse samples
- 55:54and we're in this study.
- 55:56We are collecting the stressful
- 55:59speech task we're collecting,
- 56:01e.g an we're collecting eye
- 56:03tracking an we Viper for color.
- 56:05Would we got a supplement to obtain
- 56:08data on healthy controls who will not
- 56:12receive the treatment but they will
- 56:14participate in all the assessments.
- 56:17Just so we could see what is the
- 56:20natural cost of these measures?
- 56:22Without any treatment,
- 56:23so we also have that type of competitor,
- 56:26so this is ongoing and we're really
- 56:29actively recruiting participants.
- 56:31And remember, I told you at the beginning,
- 56:34adolescence,
- 56:34social anxiety they spawned poorest, the CPT.
- 56:37That's why we're focusing on adolescents.
- 56:41Young adolescents with social
- 56:42anxiety disorder.
- 56:43We are actively recruiting for
- 56:45this trial and actually also
- 56:47for the space and CBT trial fee,
- 56:49so please you know please now that you
- 56:52know what where we are and what we're doing.
- 56:55If you have possible referrals we
- 56:57would appreciate it a great deal.
- 57:00So attention retraining is efficient and
- 57:02cost effective in a step care approach.
- 57:05That's important dissemination data.
- 57:06Attentionally training is a viable
- 57:08argument for CBT resistant pediatric,
- 57:10and what awaits discovery is what's the
- 57:12mechanism underlying attention with training.
- 57:14Because it's I mean,
- 57:16I think most of us.
- 57:17I mean, it's kind of hard to believe,
- 57:20but I mean people go through it
- 57:23and the people say hey thanks,
- 57:25this was really helpful.
- 57:26So it's not just the data that's
- 57:29showing this, but the clinical.
- 57:30Thank you,
- 57:31so I'm really intrigued by this and
- 57:34I really am so excited to figure out
- 57:37what is the mechanism underlying this.
- 57:39So the takeaways for today as I wrap
- 57:42up now is anxiety assessment methods
- 57:44are good to excellent samples.
- 57:47Inadequately diverse CPT is efficacy
- 57:49and it can be disseminated in
- 57:52an effective way.
- 57:53But we need improvement in
- 57:55terms of how we can
- 57:57enhance. After these trials that I
- 58:00showed you, I'm feeling more and more
- 58:02comfortable and I think the theory
- 58:05that research is supporting this idea,
- 58:07that of all those ways that people work
- 58:10with parents with duesing parents side
- 58:13control and negative reinforcement,
- 58:15might be a way to enhance it.
- 58:17And if we can do it using the
- 58:20type of more potent method like
- 58:24to sell digital intervention.
- 58:26Trying I'm hopeful.
- 58:27Also we can maybe enhance CBT
- 58:29with via attention retraining,
- 58:31either with step Care, CPT,
- 58:33business sense and that efficacy.
- 58:35Trial that I talked about
- 58:37is getting at the mechanism.
- 58:42Now I didn't, not Stephanie,
- 58:4310 years from now, maybe not,
- 58:45I'm joking, but you know not next year.
- 58:48But I do have when putting this together.
- 58:51This presentation I had,
- 58:52these other dad there,
- 58:54but I just didn't have time because
- 58:56moderators are really important
- 58:58part of the story which treatments
- 59:00for home and so and we're working
- 59:02on and trying to delve into that.
- 59:04And that's important.
- 59:05We also have.
- 59:06I also have shared my data with
- 59:08other people which which has allowed.
- 59:11Large studies of looking at the rates of
- 59:13change because some of these interventions.
- 59:15It's not just enough what
- 59:17works and how does it work,
- 59:19but also like what's the speed
- 59:21in which they were?
- 59:22Can we have some interesting find?
- 59:24You know, some interesting stuff on that?
- 59:26I told you about group CBT which I love
- 59:29and I didn't get into shelling them.
- 59:31But I also think that's a really
- 59:33important way of improving and
- 59:35working with children with anxiety.
- 59:37We also have a paper under
- 59:39review now 'cause we also had a.
- 59:41Project where we did attentionally
- 59:44training with subclinical subthreshold
- 59:46anxiety and we actually the bottom
- 59:48line is we found that it's helpful
- 59:50for this population too and then
- 59:53the behavioral and biological neural
- 59:55targets and then the work that's
- 59:58ongoing is the two side study the
- 01:00:00space trial with with Allie and Dylan
- 01:00:03and Hillary an elion with a grant
- 01:00:06with a postdoc with doing failure to
- 01:00:09launch where we're doing parent work.
- 01:00:11With young adults,
- 01:00:12so getting parents not to do what
- 01:00:15they do with their little kids,
- 01:00:16which is to do a lot of negative
- 01:00:19reinforcement or when Eli refers to
- 01:00:22his accommodation with doing that with
- 01:00:24young adults and then the proof of concept.
- 01:00:27So I have too many people here on this
- 01:00:31slide to thank Elianne Colorado most
- 01:00:35important people of the anxiety team and.
- 01:00:39Marissa help has a astrex next to her
- 01:00:42name because she helped me with my slide.
- 01:00:45So and she's a postgraduate
- 01:00:47associate and I have too many people.
- 01:00:50But I have to give here at the
- 01:00:52psychiatry a big shout out to both.
- 01:00:55Hillary answer Vegeta,
- 01:00:56you know I love the work I'm doing
- 01:00:59with Vegeta on mindfulness with
- 01:01:01a different population,
- 01:01:02but I'm actually really hopeful that
- 01:01:04Vegeta and I can think about doing attention,
- 01:01:07retraining and mindfulness and
- 01:01:09how those two attentional.
- 01:01:10Interventions work,
- 01:01:11and with Hillary I learn all the
- 01:01:14time so much about the brain and
- 01:01:16the brain and the behavior.
- 01:01:18And it's just a really super super
- 01:01:21exciting collaboration an you know
- 01:01:23and I have to say. Full disclosure.
- 01:01:25Hello,
- 01:01:26Ian and Vegeta are both really have
- 01:01:29become really super close friends and
- 01:01:32I just really I'm so thankful for that.
- 01:01:35Speaking of friends,
- 01:01:36I know this is very,
- 01:01:38very unusual to do this in ground rounds,
- 01:01:42but it's also really unusual
- 01:01:44to do ground rounds on zoom and
- 01:01:47so during this past year,
- 01:01:48two among my collaborators passed away.
- 01:01:51The first is the young woman
- 01:01:53who was a young mother,
- 01:01:55and they have their names.
- 01:01:57Bethany Sutherland, who passed away
- 01:02:00after not covid related, but I you know,
- 01:02:03I do want to memorialize this to her.
- 01:02:06She was a Co investigator doing
- 01:02:08the EG work in the in the attention
- 01:02:11Training study and then Bill Katinas,
- 01:02:13who you heard me mention was my best
- 01:02:16friend and collaborated FIU and he did
- 01:02:19pass away covid related and so I don't cry.
- 01:02:22I'll just leave this line from
- 01:02:24Wicked Witches because I knew you.
- 01:02:26I've been changed for good but I
- 01:02:28also know that they wouldn't want me.
- 01:02:31Bill wouldn't want me to end,
- 01:02:33he would want me to keep doing my work.
- 01:02:37And he'd be very happy that the
- 01:02:39Flowers are out an my second
- 01:02:41grandson was born during Covid Levi,
- 01:02:43and I know he'd be happy.
- 01:02:45And Ann,
- 01:02:45I know people have also adopted dogs,
- 01:02:48so I just want to say,
- 01:02:50for those of you like me, have lost people.
- 01:02:53You know, I know.
- 01:02:54I share my condolences,
- 01:02:55but our life and our work goes on and I just
- 01:02:59want to thank you very much for today's.
- 01:03:02Opportunity to present my work to you.
- 01:03:04Thank you.
- 01:03:11They thank you
- 01:03:12so much. What a spectacular
- 01:03:14presentation of your life's work,
- 01:03:16and I think it embodies
- 01:03:18sort of a very systematic.
- 01:03:21And thoughtful and clinically
- 01:03:22astute way to investigate the
- 01:03:24most effective ways to intervene,
- 01:03:26an important clinical population.
- 01:03:28I think we could all learn from
- 01:03:31this in the areas that we work in.
- 01:03:34So thank you so much for sharing all
- 01:03:37of this with us. My pleasure.
- 01:03:39I hope it was helpful and
- 01:03:41interesting. Thank you.
- 01:03:44We doing questions.
- 01:03:46Yes, Wendy, that was fabulous.
- 01:03:48It was great. Thank you vegeta.
- 01:03:50Will you my friend,
- 01:03:51it was great, but you know I
- 01:03:53have not heard you talk about.
- 01:03:55You know all of your work in this way.
- 01:03:57And so it was just.
- 01:03:59It was fantastic to really
- 01:04:01see what an important body
- 01:04:02of work in your thinking and
- 01:04:04an and growth through.
- 01:04:05It was
- 01:04:06just fantastic. Thank you.
- 01:04:07It means a lot for me
- 01:04:09to hear that from you with you.
- 01:04:11Thank you, of course. I'm
- 01:04:12totally mean it at one thing
- 01:04:14that kept coming up in my mind.
- 01:04:16And I'm sure you've thought
- 01:04:18about this and that.
- 01:04:19Maybe you have data and didn't.
- 01:04:22Then is are the effects and so
- 01:04:25our work together on parenting.
- 01:04:27It was really helpful to see your
- 01:04:30development on on including parents.
- 01:04:34And So what kept coming up in
- 01:04:37my mind was parents often,
- 01:04:39and I'm sure you've seen this,
- 01:04:41and we've talked about
- 01:04:43it. Parents of children with anxiety
- 01:04:45have anxiety themselves. A lot
- 01:04:47of times, and the question I
- 01:04:50had was even just being parents
- 01:04:52in your child anxiety studies.
- 01:04:54Did you assess parents,
- 01:04:56anxiety changes and whether
- 01:04:57the the there was some of this
- 01:05:00transfer in reduction in anxiety
- 01:05:02for parents? That was occurring,
- 01:05:04'cause I would actually be
- 01:05:06really cool because even
- 01:05:07though the target was a child,
- 01:05:09the parent is learning new ways.
- 01:05:11You know, giving up control.
- 01:05:12For example when you had that
- 01:05:14piece in there and a piece
- 01:05:16about negative reinforcement.
- 01:05:17And so anyway wanted to do.
- 01:05:19Do you see my slides again? Yes.
- 01:05:23Maybe you said it and I'm not well,
- 01:05:25no, because it's you know,
- 01:05:26I thought a lot at you.
- 01:05:28I mean how I can't even keep track?
- 01:05:30How could you keep track?
- 01:05:31Look at this first trial.
- 01:05:33We targeted payment anxiety.
- 01:05:34Vegeta yeah OK we targeted payment
- 01:05:37anxiety an we've been and so
- 01:05:38let me stop sharing the screen.
- 01:05:40And so, and this is where this is.
- 01:05:43Before I knew as much as I
- 01:05:45knew now I mean to be honest,
- 01:05:47and this is part of this is that we
- 01:05:49were trying to do too much and this is
- 01:05:52too much to do with the parents OK?
- 01:05:55Plus the CBT,
- 01:05:56that's one thing I need to say.
- 01:05:58However, now I'm going to start my share.
- 01:06:00However, this is really interesting
- 01:06:02because we actually this is in.
- 01:06:04This is close to being published.
- 01:06:05We actually have looked at Pam and anxiety
- 01:06:08and what we're finding is first of all.
- 01:06:11It's really.
- 01:06:12It's also hard to change.
- 01:06:14That's number one, but even then,
- 01:06:16even in all the studies that
- 01:06:18we've been measuring it,
- 01:06:20we only tried to change it in that one study.
- 01:06:24It didn't change,
- 01:06:25but in all the other studies we've been
- 01:06:28measuring it what we have found is it
- 01:06:30has not been a direct associated mediator.
- 01:06:33The Child Anxiety reduction,
- 01:06:35however, what we have found
- 01:06:36is that the anxious parents,
- 01:06:38if you reduce their site,
- 01:06:40the site control is really related.
- 01:06:43And by reducing the site control and
- 01:06:45easing up on the parents I control,
- 01:06:48it's actually need leading to a
- 01:06:50change in the anxiety of the parents.
- 01:06:53And I mean,
- 01:06:55of course you know it's more
- 01:06:57complicated than that.
- 01:06:58But my point is that I think the
- 01:07:01mediational changes more from
- 01:07:03side control to anxiety then.
- 01:07:05But it's an empirical question,
- 01:07:07but you know,
- 01:07:08but I actually think that because
- 01:07:11we have never found parent
- 01:07:13anxiety to be the direct link,
- 01:07:15but only fruit control and
- 01:07:17then answer your question.
- 01:07:20Yes, absolutely.
- 01:07:20And it's so interesting, but you know what?
- 01:07:22It sort of makes sense when
- 01:07:24you think about it.
- 01:07:25The task because you know,
- 01:07:26as the parents are letting
- 01:07:28up and control the child,
- 01:07:29has more otonomy the parent and they're
- 01:07:31seeing the kid doing more than maybe
- 01:07:33the parents are getting less anxious.
- 01:07:35You know?
- 01:07:35I mean, because you know
- 01:07:37another whole part of my work,
- 01:07:38which you know about is,
- 01:07:39you know,
- 01:07:40one of those articles was called
- 01:07:43directionality of change.
- 01:07:44So you know the whole directionality issue
- 01:07:46is part of what I'm speaking about now,
- 01:07:49yeah?
- 01:07:50Very interesting because so it
- 01:07:52sounds like it's complicated
- 01:07:53and some components change,
- 01:07:55but really perhaps the parent
- 01:07:57has to be the target to have the
- 01:08:00more maximum. I mean, that's empirical,
- 01:08:02but you know exactly you have the
- 01:08:04maximum amount of of of change,
- 01:08:07and so that's an interesting and maybe
- 01:08:09through space exactly. Well, that's the
- 01:08:11exactly. That's probably why you know
- 01:08:14we have that new intervention with
- 01:08:16space and we'll see how that goes.
- 01:08:19Thank you, it's very interesting,
- 01:08:20but it's a really interesting question.
- 01:08:22Thank you for that.
- 01:08:33Wendy, this is Chris Pittenger.
- 01:08:34Thank you for a wonderful talk and such.
- 01:08:37It was great to see it all put together.
- 01:08:41Message I'm sorry I can't put
- 01:08:42your name up as a collaborator.
- 01:08:44It almost happened these days.
- 01:08:46Will work on that.
- 01:08:48It was sort of implicit.
- 01:08:49It's at least it seemed implicit to me in the
- 01:08:52way you were presenting that you're
- 01:08:53thinking of anxiety appropriately.
- 01:08:54So trans diagnostic construct.
- 01:08:55You know you're looking at
- 01:08:56these different populations,
- 01:08:57but the concepts and the structures
- 01:08:59that you're targeting are the same.
- 01:09:00Whether it's social anxiety or phobia,
- 01:09:02whatever. At least that was my.
- 01:09:04My impression is to the extent
- 01:09:06that that's true, I wonder.
- 01:09:08What you think about how these
- 01:09:10structures and targets of treatment
- 01:09:12generalize to other disorders that
- 01:09:13are characterized by prominent
- 01:09:14anxiety but also other things?
- 01:09:16And the two obvious ones that are
- 01:09:18occurring to me or anxious OC D and
- 01:09:21trauma associated anxiety where you
- 01:09:22have anxiety is a prominent source of
- 01:09:24clinical distress in a targeted treatment.
- 01:09:26But you also have something else.
- 01:09:29That that's going on, and so so.
- 01:09:31So what do you think?
- 01:09:32I mean, starting with this sort of the pure,
- 01:09:35the anxiety make makes a lot of sense,
- 01:09:37but I wonder about generalization of this
- 01:09:39structures to those adjacent conditions.
- 01:09:42Yeah, I mean it's a really great
- 01:09:44question and I and it hasn't been
- 01:09:47studied and it certainly is important.
- 01:09:49Thing to study I I guess my own so I don't.
- 01:09:52I think it's a really great question.
- 01:09:54I I will just throw out one thought
- 01:09:56though that I have and what I've learned
- 01:09:59frankly and actually I was in the first
- 01:10:01to say this Alan Kasten back in 99.
- 01:10:03You know mode about this but when I
- 01:10:05go back then I go well you know he
- 01:10:07always had such foresight because he
- 01:10:09actually said this and I've learned
- 01:10:11this in the work that I presented.
- 01:10:13You know that the mechanisms of an onset
- 01:10:15of a disorder is not necessarily the
- 01:10:17same mechanism in a treatment reduction.
- 01:10:19Approach.
- 01:10:20You know, and I see that now because
- 01:10:23you know Pam and anxiety clearly is
- 01:10:26involved in maintaining anxiety clearly,
- 01:10:28but whether or not that's the
- 01:10:31most proxamol mechanism.
- 01:10:32That's an empirical well.
- 01:10:34I've already shown empirically,
- 01:10:35it's it doesn't seem to be.
- 01:10:37It doesn't mean it's not
- 01:10:38important for maintenance,
- 01:10:39but whether or not you want to make that the
- 01:10:41proximal mechanism in your intervention.
- 01:10:43So I guess the back to you like
- 01:10:46I think it could make sense,
- 01:10:48but I I guess I'm just saying that
- 01:10:49even if those mechanisms are involved
- 01:10:51in the maintenance of those problems,
- 01:10:54it's an empirical question.
- 01:10:55Just like an anxiety.
- 01:10:56If they were maintained in the
- 01:10:58reduction in a treatment intervention.
- 01:11:01Thanks, thank you for the question.
- 01:11:03Yeah it makes me think we
- 01:11:04should be measuring under.
- 01:11:05We do measure depression and we do have
- 01:11:07the aidas and all the other treatments.
- 01:11:09So you know we certainly can
- 01:11:10look at that more carefully.
- 01:11:11But and also like yeah anyway, thank you.
- 01:11:15Thank you, thank you very much.
- 01:11:17Yeah thanks. Hi Randy, Andy
- 01:11:18Morgans. I thought I have a question for you.
- 01:11:21I really enjoyed the presentation. Thank you.
- 01:11:24I I wanted to ask you a little more
- 01:11:26about the thread attention bias you know,
- 01:11:29does it change from people who've
- 01:11:31gone through CBT because they know it
- 01:11:33is so quick that's the threshold of
- 01:11:35consciousness responding and I was just
- 01:11:37wondering if if you know anything about
- 01:11:40does it shift after people have done
- 01:11:42a course of Skippy? There's the attention.
- 01:11:45His attention by us, so the
- 01:11:47measuring of attention by so you
- 01:11:49know the reason why we got this R
- 01:11:5101 this to side R1 is because the
- 01:11:53measure of attention bias has been
- 01:11:55really crappy with this that probe
- 01:11:57and so you know it's not reliable.
- 01:11:59It's really not good,
- 01:12:00and so and so now we're doing the
- 01:12:03EG and we're doing the eye tracking.
- 01:12:05So I I honestly don't know
- 01:12:06the answer with children.
- 01:12:08I don't know if it's been done,
- 01:12:10it might be done with adults, but you know,
- 01:12:12I I'm sorry I don't know the answer.
- 01:12:15Do like a saver pal and I'll
- 01:12:17get back to you on that.
- 01:12:19You know, no sure.
- 01:12:20Yeah, I.
- 01:12:20I mean I I don't know off the top
- 01:12:22of my head if if attempt but I only
- 01:12:24can say that the measurement is bad.
- 01:12:27You know, you know that that pro indexes,
- 01:12:29yeah?
- 01:12:31Years programming yeah yeah,
- 01:12:32we use your ears and you know and yeah
- 01:12:33he is also like doing what we're doing.
- 01:12:36You know he does AEG and he does eye tracking
- 01:12:38and with Danny of course you know he.
- 01:12:40I mean we're involved with Danny and with
- 01:12:42Danny with doing it also with the imaging.
- 01:12:44Wonderful, I'll follow up with you that
- 01:12:46I will follow up with you. OK, thank
- 01:12:49you. Thank you, thank you.
- 01:12:59So I am sorry I had
- 01:13:02a question. Last question, do I have time?
- 01:13:06Yeah, this would be the last question,
- 01:13:08so thanks. So Doctor Silverman is there.
- 01:13:12Do you see this working is
- 01:13:14in a prevention model too.
- 01:13:18Yes. The absolutely,
- 01:13:20absolutely, absolutely.
- 01:13:21Especially since I told
- 01:13:22you we did the attention.
- 01:13:24Retraining was sub clinical
- 01:13:25subclinical I mean I said like I
- 01:13:27know my I you know I do really want
- 01:13:30to do an effectiveness trial with
- 01:13:32attention retraining and I wanted
- 01:13:33to set care and now I'm going
- 01:13:35to bring the jitter in to do the
- 01:13:38mindfulness part of it and Hillary
- 01:13:40to do the brain measurements.
- 01:13:42But that's I,
- 01:13:42I definitely think it's a step care step.
- 01:13:45CPK is sort of like a prevention
- 01:13:47approach to some extent.
- 01:13:49It can be conceptualized that way.
- 01:13:51Thank you. Application area.
- 01:13:56Great, well thank you so much and
- 01:13:59thanks to everyone for attending and
- 01:14:01traffic tarcan Wendy. I'm going to
- 01:14:03send you dates for four years from
- 01:14:06now so we should schedule it now.
- 01:14:08No no, no give me more than four years.
- 01:14:13What give me more employees?
- 01:14:17I I know I was flossing.
- 01:14:19Sure could call it that title,
- 01:14:21but I said what the heck,
- 01:14:23terrific well anyway.
- 01:14:23Thank you so much.
- 01:14:25Appreciate OK, thank.